ClinicalTrials.Veeva

Menu

Evaluation of a Decision Aid Tool in Rectal Cancer patiënts

G

Ghent University Hospital (UZ)

Status

Completed

Conditions

Low Anterior Resection Syndrome
Rectal Cancer

Treatments

Behavioral: Delphi Procedure and interviews

Study type

Observational

Funder types

Other

Identifiers

NCT04938336
BC-10030

Details and patient eligibility

About

Adapt and evaluate a decision aid for patients with rectal cancer. Phase 1 : decision aid testing (Delphi) multicentric Phase 2: pilot test decision aid

Full description

Adapt and evaluate a decision aid for patients with rectal cancer. Phase1: decision aid testing (Delphi) A pilot version of the Belgian decision aid was developed and validated through a double Delphi procedure. In this study, the assessment is extended to several multicentre experts. The panel consists of ten experts who have extensive knowledge in the field of rectal cancer or scientific research. They are asked to evaluate the information and questions on accuracy, clarity, readability and relevance. They score the items of the decision aid using a 4-point Likert-type scale (one (one = totally irrelevant; four = very relevant) and a dichotomous scale (one = clear, two = not clear) to assess relevance and clarity of wording, respectively (see Appendix 2 to this application). To quantify the degree of content validity, the Content Validity Index (CVI) is used.

Phase2: pilot test decision aid The final step of the study is a pilot test of the decision aid with patients who will undergo surgery/watch and wait strategy in the near future and with healthcare professionals who work with the decision aid. The aim is to test the acceptability of the decision aid with the patient and the ease of use with the healthcare professional. With the feedback from the patients and the healthcare professional, the decision aid can be further refined.

During the consultation in which the intervention is discussed, the consent to participate will be asked of the patient and also of the informal carer who may be present at that moment. Participation in the study means that during this consultation, the caregiver involved will go through the decision aid completely with the patient and any informal carer. After the intervention, they will be asked to give feedback on their experiences with the use of the decision aid. This will be done by means of an interview for the patients, informal carers and care workers involved. The interview with the patient (and informal carer if applicable) will take place at home or in the hospital, depending on their preference. The interview with the caregiver takes place in the hospital where the caregiver works. If the current Covid-19 pandemic does not allow for a visit to the patient's home or to another hospital, the interviews will be conducted by telephone or video call.

Enrollment

70 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Delphi procedure

Inclusion Criteria:

  • expert healthcare professionals caring for patients with rectal cancer

Exclusion Criteria:

  • none

Interviews Inclusion criteria

  • Patients in which the decision aid was tested
  • patients with a tumor in the last 10cm of the rectum
  • healthcare professionals who have used the decision aid tool
  • informal carer indicated by the patient Exclusion
  • patients who have no treatment choice due to oncological reasons

Trial design

70 participants in 2 patient groups

expert healthcare professionals
Description:
Delphi Procedure
Treatment:
Behavioral: Delphi Procedure and interviews
healthcare professionals, patients and informal carers
Description:
interviews
Treatment:
Behavioral: Delphi Procedure and interviews

Trial contacts and locations

2

Loading...

Central trial contact

Eva pape

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems